FR2194425B1 - - Google Patents

Info

Publication number
FR2194425B1
FR2194425B1 FR7326500A FR7326500A FR2194425B1 FR 2194425 B1 FR2194425 B1 FR 2194425B1 FR 7326500 A FR7326500 A FR 7326500A FR 7326500 A FR7326500 A FR 7326500A FR 2194425 B1 FR2194425 B1 FR 2194425B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7326500A
Other versions
FR2194425A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ERREKAPPA EUROTERAPICI Sas
Original Assignee
ERREKAPPA EUROTERAPICI Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ERREKAPPA EUROTERAPICI Sas filed Critical ERREKAPPA EUROTERAPICI Sas
Publication of FR2194425A1 publication Critical patent/FR2194425A1/fr
Application granted granted Critical
Publication of FR2194425B1 publication Critical patent/FR2194425B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
FR7326500A 1972-08-02 1973-07-19 Expired FR2194425B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (2)

Publication Number Publication Date
FR2194425A1 FR2194425A1 (fr) 1974-03-01
FR2194425B1 true FR2194425B1 (fr) 1976-04-09

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7326500A Expired FR2194425B1 (fr) 1972-08-02 1973-07-19

Country Status (29)

Country Link
US (1) US3893999A (fr)
JP (1) JPS5235726B2 (fr)
AR (1) AR195350A1 (fr)
AT (1) AT341684B (fr)
AU (1) AU474015B2 (fr)
BE (1) BE802981A (fr)
CA (1) CA1006872A (fr)
CH (1) CH592112A5 (fr)
CS (1) CS195254B2 (fr)
DD (1) DD107461A5 (fr)
DE (1) DE2336401C3 (fr)
DK (1) DK131868C (fr)
ES (1) ES417377A1 (fr)
FI (1) FI52466C (fr)
FR (1) FR2194425B1 (fr)
GB (1) GB1425384A (fr)
HK (1) HK31580A (fr)
HU (1) HU167266B (fr)
IE (1) IE37913B1 (fr)
IL (1) IL42764A (fr)
MX (1) MX4544E (fr)
NL (1) NL152864B (fr)
NO (1) NO137941C (fr)
PL (1) PL87381B1 (fr)
RO (1) RO63451A (fr)
SE (1) SE400085B (fr)
SU (1) SU646915A3 (fr)
YU (1) YU36037B (fr)
ZA (1) ZA734876B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
DE3874352T2 (de) * 1987-10-09 1992-12-17 Vincenzo Zappia Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
WO2006079212A1 (fr) 2005-01-26 2006-08-03 Diamedica Inc. Utilisation du compose s-adenosylmethionine, de la vitamine e, et de la vitamine c pour traiter les lesions hepatiques et la resistance a l'insuline causees par le stress oxydatif
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060629A1 (it) 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
CA2677053C (fr) * 2007-01-31 2016-03-15 Methylation Sciences International Srl Formulations pharmaceutiques a liberation prolongee de s-adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2696879A4 (fr) * 2011-04-15 2014-11-26 Scimar Ltd Utilisation de s-adénosylméthionine, de vitamine e et de vitamine c dans la prévention et le traitement d'un dysfonctionnement cardiovasculaire
CA2888302C (fr) 2012-10-17 2016-05-31 Methylation Sciences International Srl Compositions comprenant de la s-adenosylmethionine et un ester d'acide gallique
KR102186066B1 (ko) 2013-01-16 2020-12-04 허버트 샘-이 엘엘씨 S-아데노실-l-메티오닌의 안정한 인돌-3-프로피오네이트염

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Also Published As

Publication number Publication date
ES417377A1 (es) 1976-02-16
FI52466B (fr) 1977-05-31
YU36037B (en) 1981-11-13
DD107461A5 (fr) 1974-08-05
SU646915A3 (ru) 1979-02-05
HU167266B (fr) 1975-09-27
IL42764A0 (en) 1974-01-14
CH592112A5 (fr) 1977-10-14
DE2336401B2 (de) 1979-07-12
AU474015B2 (en) 1976-07-08
PL87381B1 (fr) 1976-06-30
AU5868073A (en) 1975-01-30
NL7310706A (fr) 1974-02-05
AT341684B (de) 1978-02-27
BE802981A (fr) 1973-11-16
US3893999A (en) 1975-07-08
IE37913B1 (en) 1977-11-09
MX4544E (es) 1982-06-08
IL42764A (en) 1976-04-30
DK131868C (da) 1976-03-08
FI52466C (fi) 1977-09-12
YU203073A (en) 1981-04-30
HK31580A (en) 1980-06-20
JPS5235726B2 (fr) 1977-09-10
RO63451A (fr) 1978-07-15
CS195254B2 (en) 1980-01-31
DK131868B (da) 1975-09-15
DE2336401A1 (de) 1974-02-14
ZA734876B (en) 1974-06-26
IE37913L (en) 1974-02-02
GB1425384A (en) 1976-02-18
NO137941B (no) 1978-02-13
CA1006872A (en) 1977-03-15
SE400085B (sv) 1978-03-13
FR2194425A1 (fr) 1974-03-01
AR195350A1 (es) 1973-09-28
DE2336401C3 (de) 1980-03-13
NO137941C (no) 1978-05-31
JPS4992215A (fr) 1974-09-03
ATA664173A (de) 1977-06-15
NL152864B (nl) 1977-04-15

Similar Documents

Publication Publication Date Title
FR2194425B1 (fr)
JPS4949038A (fr)
FR2204277A5 (fr)
JPS4960466A (fr)
JPS4989629A (fr)
JPS4910192A (fr)
JPS4938370A (fr)
CS157935B1 (fr)
CS157798B1 (fr)
JPS4943791U (fr)
JPS4940306U (fr)
CS158844B1 (fr)
NO130273C (fr)
CS158025B1 (fr)
CS153392B1 (fr)
CS157585B1 (fr)
CS155021B1 (fr)
CS157403B1 (fr)
JPS4928127A (fr)
JPS4921557U (fr)
CS156994B1 (fr)
CS152250B1 (fr)
CH560215A5 (fr)
CH1352272A4 (fr)
BG19538A1 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
CD Change of name or company name
CN Change in juridical nature
TP Transmission of property